An Unbalanced Exon-Expression qPCR-based Assay for Detection of ALK Translocation (Fusion) in Lung Cancer
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2017, Vol 4, Issue 1
Abstract
Non-Small Cell Lung Cancer (NSCLC) constitutes 85-90% of all lung cancer. Accurate diagnosis and selection of targeted therapies in lung cancer depends on robust detection of the molecular events that underlie its pathogenesis. Since patients having a rearrangement in the Anaplastic Lymphoma Kinase (ALK) gene respond well to treatment with crizotinib, identification of such ALK mutations is necessary for the successful treatment of NSCLC. The most common rearrangement of the ALK gene in NSCLC involves fusion with echinoderm microtubule-associated protein-like 4 (EML 4) as the upstream partner. Current testing methods for this rearrangement (IHC and/or FISH) can be very subjective due to high operator variability. They require expert interpretation by a pathologist and have a long turnaround time. The FDAapproved Fluorescence In Situ Hybridization (FISH) test has been shown to lack sensitivity and is generally acknowledged to fail to detect rearrangements in up to 60% of patients. Here, we have adapted an approach described earlier and optimized it for use with degraded RNA obtained from Formalin-Fixed Paraffin-Embedded (FFPE) sections. This method is based on the unbalanced expression of 5’- and 3’-regions (exons) of the ALK gene. It is also applicable to the detection of other cancer-relevant gene rearrangements e.g. ROS 1 or RET that result in increased expression of the 3’-kinase domain. Patients with these rearrangements have been shown to respond to crizotinib and cabozantinib, respectively. Using NSCLC cell lines we demonstrate that our method is cost-effective, reproducible, sensitive, objective, and easy to use. Unlike FISH, it does not require interpretation by several scorers and it can be performed in any clinical laboratory with access to a qPCR instrument. Here we present the protocol for the method and validation with 197 clinical samples.
Authors and Affiliations
Rama K. Singh
Keywords
Related Articles
- EP ID EP546428
- DOI 10.17140/PRRMOJ-4-132
- Views 203
- Downloads 0
Diaphragm Ultrasonography as a Tool To Assess the Respiratory Issues of a Patient With Amyotrophic Lateral Sclerosis (ALS)
A 73-year-old woman with Amyotrophic Lateral Sclerosis (ALS) presented at a universityaffiliated community hospital with increasing shortness of breath. She was diagnosed with ALS 2 years prior to this event, and she had...
Flapping Tremor as a Diagnostic Tool for Evaluation of Hypercapnia
A 76 year-old woman was admitted to our hospital because of aspiration pneumonia. Four days after initiation of the antibiotic treatment, her respiratory status became to be better; however, hypoxemia was recurred with t...
The Role of Vital Signs in Predicting Cardiac Tamponade in Asymptomatic Patients with Malignancy: Associated Pericardial Effusion
Background: Cardiac tamponade is a potentially life-threatening complication in patients with advanced lung cancer or other metastatic malignant diseases. However, few reports described how to assess the risk for develop...
Balloon Pulmonary Angioplasty (BPA) and Rehabilitation for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH) has a poor prognosis because of increased pulmonary arterial pressure (PAP) causing pulmonary hypertension and progressive right-sided heart failure.1,2 Typical sympt...
Modern Technology in Respiratory Medicine: Lung Ultrasonography–Is it Time for the Stethoscope to Give Up its Throne?
The year 2016 marks the 200th anniversary of the invention of the stethoscope by Dr. Réne Théophile Hyacinthe Laennec. He was first inspired in September 1816 when he observed 2 children playing with a long piece of soli...